Clinical Trials Browser

Interventional × Drug Combinations × 90 days × Clear all

NCT07220616 2026-05-08

A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies

Phase 1/2 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms